Bioactive lipids such as the prostaglandins have been reported to have various cytoprotective or toxic properties in acute and chronic neurological conditions. The roles of PGF 2α and its receptor (FP) are not clear in the pathogenesis of ischemic brain injury. Considering that this G-protein coupled receptor has been linked to intracellular calcium regulation, we hypothesized that its blockade would be protective. We used FP antagonist (AL-8810) and FP receptor knockout (FP −/− ) mice in in vivo and in vitro stroke models. Mice that were treated with AL-8810 had 35.7 ± 6.3% less neurologic dysfunction and 36.4 ± 6.0% smaller infarct volumes than did vehicle-treated mice after 48 h of permanent middle cerebral artery occlusion (pMCAO); FP −/− mice also had improved outcomes after pMCAO. Blockade of the FP receptor also protected against oxygen-glucose deprivation (OGD)-induced cell death and reactive oxygen species formation in slice cultures. Finally, we found that an FP receptor agonist dose dependently increased intracellular Ca 2+ levels in cultured neurons and established that FP-related Ca 2+ signaling is related to ryanodine receptor signaling.
Introduction
We and others have described that the bioactive lipids, such as the prostaglandins, might affect neuronal outcomes after a variety of brain insults, including hypoxia, inflammation, and excitotoxicity (Dore et al., 2003) . Therefore, we have focused our research on the unique properties of the prostaglandins and their receptors (Doré, 2006) . Cyclooxgenases are the rate limiting enzymes for the conversion of arachidonic acid to prostaglandin PGH 2 , which is metabolized by specific prostaglandin synthases to at least five structurally related bioactive lipid molecules, including PGE 2 , PGD 2 , PGF 2α , PGI 2 , and thromboxane A 2 (Doré, 2006) . PGF 2α , which is synthesized from PGH 2 via PGF synthase, plays a major role in initiation of parturition, renal function, control of cerebral blood flow autoregulation in newborn piglets (Chemtob et al., 1990) , contraction of arteries, and myocardial dysfunction (Takayama et al., 2005) . Recently, a report suggested that FP signaling can facilitate idiopathic pulmonary fibrosis (Oga et al., 2009) . Although the critical biological functions of PGF 2α were reported to be mediated through activation of the FP receptor, the effect and mechanism of FP activation are not well understood in ischemic stroke, especially in regard to stroke-related Ca 2+ signaling. Based on reports of the Prostaglandin F (FP) receptor's presence in the central nervous system and its physiologic properties in regard to stroke and Ca 2+ signaling (Abramovitz et al., 1994; Kitanaka et al., 1994; Saleem et al., 2009a) , we hypothesize that activation of the FP receptor subsequent to injury contributes to excitotoxic and ischemic damage. Therefore, our goal is to investigate the role of the FP receptor in the brain and in neuronal cells and to further address relevant signaling pathways. We have established the importance of the PGE 2 EP1 receptor in ischemic models (Ahmad et al., 2008) . Based on its similarity to the EP1 receptor in terms of amino acid sequence and cell signaling, we hypothesize that the FP receptor might contribute to excitotoxic and ischemic brain damage similar to that caused by the EP1 receptor. We speculate that the mechanism of injury might stem from dysregulation of Ca 2+ homeostasis. Therefore, we studied the role of the FP receptor in a mouse model of permanent middle cerebral artery occlusion (pMCAO) and in ischemia-related Ca 2+ signaling in cultured neurons. 
